Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Consumerism

How not to be fooled, and why the old way is old news.

Principal, Health & Life Sciences, Oliver Wyman

Oral health can be the key driver of patients' ER bills. Proper care for the body’s “gateway” is a compelling value proposition for consumers and the healthcare ecosystem.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Asian healthcare is undergoing major disruption, and a new healthcare environment is emerging.

Partner, Head of Health & Life Sciences, Asia Pacific, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

There's big buzz around consumer behavior driving outcomes. But clinical data doesn't yet align with behavioral data.

Principal, Health & Life Sciences, Oliver Wyman

Healthcare companies should look to rebuild trust by doubling down on employee communications and fostering engagements that are driven by employees themselves.

Global Chair, Health, Edelman

Insights in your inbox

Subscribe

They Just Have to Persuade People to Like Them

Oliver Wyman research examines whether consumers are using healthcare’s “new front door”, and if not, why not.

Principal, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Pharma companies and providers in search of better solutions must look to the patient experience for answers.

Partner, Digital & Analytics, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

2018 was a big year for industry news. Here's what might happen next in artificial intelligence, the 2020 presidential election, pharma, and more.

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Despite its unstable global geopolitical climate, Asia is primed for steady change this year in healthcare.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Head of Health & Life Sciences, Asia Pacific, Oliver Wyman

Some of our 2018 predictions on consolidation, pharma, and investment came true, while others were less predictable.

Principal, Oliver Wyman

Insights in your inbox

Subscribe